A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD

COPD, Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:
A Randomized, Double-Blind, Two Treatment, Two Period, Chronic Dosing (2 Weeks), Cross-Over, Multi-Center Study to Evaluate the Effects of PT001 and PT005 on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD.

Status Completed

Clinical Trial Summary

To assess the effect of treatment with Glycopyronnium (GP) MDI administered twice daily (BID) and Formoterol Fumarate (FF) MDI administered BID on specific image-based airway volumes and resistance in subjects with moderate to severe chronic obstructive pulmonary disease (COPD) following chronic dosing after approximately two weeks treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

COPD, Chronic Obstructive Pulmonary Disease
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive

Clinical Trial Details

NCT number	NCT02937584
Study type	Interventional
Source	Pearl Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	December 29, 2016
Completion date	May 28, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05016466` - GOLD 0 - DLCO 1: A Look Beyond the Obstruction. Is Spirometry Enough for COPD (Chronic Obstructive Pulmonary Disease) Screening?
Not yet recruiting	`NCT05114434` - Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)
Recruiting	`NCT05297279` - OMEGA - Dietary Intervention - COPD Trial	N/A
Recruiting	`NCT03658538` - Motivational Interviewing and Air Cleaners for Smokers With COPD (MOVE COPD)	N/A
Not yet recruiting	`NCT04820257` - Home-based Pulmonary Rehabilitation for COPD Patients	N/A